A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication

A Zullo, Cesare Hassan, V De Francesco, R Lorenzetti, M Marignani, S Angeletti, E Ierardi, S. Morini

Research output: Contribution to journalArticle

89 Citations (Scopus)


Helicobacter pylori infection persists in a considerable proportion of patients after both first- and second-line current treatments. A standard therapy for re-treatment in such refractory patients is still lacking. This study aimed to evaluate the efficacy of a levofloxacin-amoxycillin combination in patients who previously failed two or more therapeutic attempts.
Original languageEnglish
Pages (from-to)232-236
Number of pages5
JournalDigestive and Liver Disease
Publication statusPublished - 2003
Externally publishedYes


  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Aged
  • Amoxicillin
  • Anti-Infective Agents
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Breath Tests
  • Drug Administration Schedule
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Endoscopy, Digestive System
  • Female
  • Glossitis
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Male
  • Middle Aged
  • Ofloxacin
  • Omeprazole
  • Penicillins
  • Prospective Studies
  • Treatment Outcome
  • Urea


Dive into the research topics of 'A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication'. Together they form a unique fingerprint.

Cite this